Rentschler Biopharma Takes Home the Gold in 20th Annual Team Massachusetts Economic Impact Awards
March 13, 2024 09:30 ET
|
Rentschler Biopharma SE
Company honored with highest award for Central Massachusetts regionNew state-of-the-art Rentschler Biopharma Manufacturing Center (RBMC) facility slated to open for business later this year ...
Rentschler Biopharma appoints Benedikt von Braunmuehl as Chief Executive Officer
September 19, 2023 05:00 ET
|
Rentschler Biopharma SE
Benedikt von Braunmuehl, a transformational leader with a 30-year track record in the global healthcare industry, is named CEO Rentschler Biopharma SECompany also announces appointment of Tom Roberts,...
Rentschler Biopharma Receives Worcester Business Journal 2023 Manufacturing Excellence Award
April 27, 2023 10:00 ET
|
Rentschler Biopharma SE
Company presented with Workforce Development Award, recognizing partnership with MassBioEd and WPI to train people for biotech manufacturing positions Company honored at Worcester Business Journal...
Rentschler implements innovative learning program in collaboration with MassBioEd and WPI
December 07, 2022 09:00 ET
|
Rentschler Biopharma SE
LAUPHEIM, Germany and MILFORD, Mass., Dec. 07, 2022 (GLOBE NEWSWIRE) -- Rentschler Biopharma, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, is...
Rentschler Biopharma appoints Mark Caswell as Vice President, Site Head for US Facility
August 18, 2022 09:03 ET
|
Rentschler Biopharma SE
LAUPHEIM, Germany and MILFORD, Mass., Aug. 18, 2022 (GLOBE NEWSWIRE) -- Rentschler Biopharma, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals,...
Milford Companies Sells Pipeline Construction Division to Bull Creek Pipeline Services
December 01, 2021 11:00 ET
|
The Milford Companies
MIDLAND, Texas, Dec. 01, 2021 (GLOBE NEWSWIRE) -- Milford Companies announced today that it has entered into a definitive agreement to sell its pipeline construction division to Bull Creek Pipeline...
Rentschler Biopharma breaks ground at new U.S. production site in greater Boston
August 12, 2021 08:00 ET
|
Rentschler Biopharma SE
New facility, adjacent to existing Milford, MA site, to significantly expand cGMP manufacturing capacity, accelerating clinical and commercial supply of essential biopharmaceuticalsSite will employ...
Leukocare Announces USD 17.5 Million Financing Round to Further Expand US Business and Bioinformatics Activities
June 23, 2021 03:30 ET
|
LEUKOCARE AG
MARTINSRIED, Germany and MUNICH, Germany and MILFORD, Mass., June 23, 2021 (GLOBE NEWSWIRE) -- Leukocare AG, a biotechnology company specialized in the field of biopharmaceutical formulation...
Rentschler Biopharma appoints Dr. Martin Kessler as Chief Executive Officer of U.S. Subsidiary and as Senior Vice President Transformation
March 31, 2021 04:00 ET
|
Rentschler Biopharma SE
LAUPHEIM, Germany and MILFORD, Mass., March 31, 2021 (GLOBE NEWSWIRE) -- Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals,...
Rentschler Biopharma and Leukocare extend service offering with joint U.S. site
March 22, 2021 05:00 ET
|
Rentschler Biopharma SE
Leukocare joins Rentschler Biopharma in the U.S., facilitating integrated alliance capabilities and enhanced service for North American clientsClient-focused approach and integration of best-in-class...